Ionis Pharmaceuticals (IONS) PT Raised to $64 at Needham & Company as ENDEAR Study Halted Early for Efficacy
Go back to Ionis Pharmaceuticals (IONS) PT Raised to $64 at Needham & Company as ENDEAR Study Halted Early for Efficacy| (NASDAQ: IONS) | Delayed: 86.33 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $86.33 | 52 Week High | $62.68 | |||
| Open | $86.33 | 52 Week Low | $19.59 | |||
| Day High | $86.33 | P/E | N/A | |||
| Day Low | $86.33 | EPS | $0.00 | |||
| Volume | 2,795 | |||||

